Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines (Q28260203)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hans-Dieter Volk

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

G Gruetz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A C Looman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

K Asadullah

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

W Sterry

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

R Sabat

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

K Wolk

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

1 October 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Genes and Immunity

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

702-714

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Interleukin-10 and related cytokines and receptors

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

IL-28 and IL-29: newcomers to the interferon family

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Biological activity of interleukins-28 and -29: comparison with type I interferons

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

IL-22 increases the innate immunity of tissues

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

The human interferon alpha/beta receptor: characterization and molecular cloning

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29)

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1038/GENE.2009.72

21 April 2017

Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Antitumor activity of IFN-lambda in murine tumor models

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Next generation of immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Current treatment options in hairy cell leukemia and hairy cell leukemia variant

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Management issues in chronic viral hepatitis: hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Human interferon-lambda3 is a potent member of the type III interferon family.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Type III and I interferons increase HIV uptake and replication in human cells that overexpress CD4, CCR5, and CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Cutting edge: immune cells as sources and targets of the IL-10 family members?

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Differential receptor subunit affinities of type I interferons govern differential signal activation.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytes

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

21 January 2018

Interferon-beta treatment for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

7 January 2021

based on heuristic

inferred from DOI database lookup

Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there an interaction between interleukin-10 and interleukin-22?

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2009.72

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/GENE.2009.72

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Dimensions Publication ID

0 references

release_2ijtpk5mmvfwfflwhfhc2o2vou

1 reference

https://api.fatcat.wiki/v0/release/2ijtpk5mmvfwfflwhfhc2o2vou

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19798076%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

ResearchGate publication ID

0 references

Springer Nature article ID

10.1038/gene.2009.72

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28260203&oldid=1838929439"